Granulocyte-colony stimulating factor (G-CSF) reprograms bone marrow granulopoiesis, resulting in non-inhibitory myeloid cells within mIDH1 glioma TME and enhancing the efficacy of immune-stimulatory gene therapy (TK/Flt3L) (250, 251). The gene discussed is CSF3; the disease is central nervous system cancer.